ADC Therapeutics SA Severance Costs
ADC Therapeutics SA (ADCT) reported Severance Costs of $2.67 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2026-08-13
- ADC Therapeutics SA severance costs for the quarter ending 2026-06-30 was $2.67M, a 59.95% decline year-over-year.
- ADC Therapeutics SA severance costs for the quarter ending 2025-09-30 was -$450.00K.
- ADC Therapeutics SA severance costs for the quarter ending 2025-06-30 was $6.68M.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month |
|---|---|---|---|
| 2026-06-30 | $2.67M 10-Q · filed 2026-08-13 | $2.67M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$450.00K 10-Q · filed 2025-11-10 | $6.23M derived: sum of 2 quarters · filed 2026-08-13 | $6.23M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $6.68M 10-Q · filed 2026-08-13 | $6.68M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |